A validated clinical tool for the prediction of varices in PBC: The Newcastle Varices in PBC Score

Patanwala, Imran, McMeekin, Peter, Walters, Ruth, Mells, George, Alexander, Graeme, Newton, Julia, Shah, Hemant, Coltescu, Catalina, Hirschfield, Gideon, Hudson, Mark and Jones, Dave (2013) A validated clinical tool for the prediction of varices in PBC: The Newcastle Varices in PBC Score. Journal of Hepatology, 59 (2). pp. 327-335. ISSN 0168 8278

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1016/j.jhep.2013.04.010


Background & Aims - Gastro-oesophageal varices (GOV) can occur in early stage primary biliary cirrhosis (PBC), making it difficult to identify the appropriate time to begin screening with oesophageo-gastro-duodenoscopy (OGD). Our aim was to develop and validate a clinical tool to predict the probability of finding GOV in PBC patients.

Methods - A cross-sectional retrospective study analysing clinical data of 330 PBC patients who underwent an OGD at the Freeman Hospital, Newcastle was used to create a predictive tool, the Newcastle Varices in PBC (NVP) Score, that was externally validated in PBC patients from Cambridge (UK) and Toronto (Canada).

Results - 48% of the Newcastle, 31% of the Cambridge, and 22% of the Toronto cohorts of PBC patients had GOV. Twenty-five percent (95% CI 18–32%) of the Newcastle cohort had GOV diagnosed at an index variceal bleed. Of the others, 37% (95% CI 28–46%) bled after a median of 1.5 years (IQR 3.75). Transplant-free survival was significantly better in those without GOV than in those with GOV (p <0.001), but similar in patients with GOV that bled and those that did not (p = 0.1). The NVP score (%Probability) = 1/[1 + exp^−(9.186 + 0.001 * alkaline phosphatase in IU − 0.178 * albumin in g/L − 0.015 * platelet × 109) was validated in 2 external cohorts and was highly discriminant (AUROC 0.86). Cost consequences analyses revealed the NVP score to be as accurate as, but more economical than using either OGD directly or other risk scores for screening PBC patients.

Conclusions - The NVP score is an inexpensive, non-invasive, externally validated tool that accurately predicts GOV in PBC.

Item Type: Article
Uncontrolled Keywords: Liver disease; Chronic; Portal hypertension; Health economics
Subjects: B900 Others in Subjects allied to Medicine
Department: Faculties > Health and Life Sciences > Nursing, Midwifery and Health
Depositing User: Becky Skoyles
Date Deposited: 12 Aug 2015 15:21
Last Modified: 12 Oct 2019 15:27
URI: http://nrl.northumbria.ac.uk/id/eprint/23550

Actions (login required)

View Item View Item


Downloads per month over past year

View more statistics